# Konstantinos Leventakos

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/konstantinos-leventakos/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,121 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 27 |
| i10-index | 56 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5023803145 |
| ORCID iD | 0000-0001-9784-8603 |
| Works | 280 |

## Researcher papers

- [Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation](https://scholariq.org/papers/adagrasib-in-non-small-cell-lung-cancer-harboring-a-i-kras-sup-g12c-sup-i/)
- [Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years](https://scholariq.org/papers/representation-of-minorities-and-women-in-oncology-clinical-trials-review-of-the/)
- [Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study](https://scholariq.org/papers/epidemiology-and-sites-of-involvement-of-invasive-fungal-infections-in-patients/)
- [MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with <i>MTAP</i> -Deleted Cancer](https://scholariq.org/papers/mrtx1719-is-an-mta-cooperative-prmt5-inhibitor-that-exhibits-synthetic-lethality/)
- [Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance](https://scholariq.org/papers/fitness-and-virulence-costs-of-candida-albicans-fks1-hot-spot-mutations/)
- [Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them?](https://scholariq.org/papers/fungal-infections-in-leukemia-patients-how-do-we-prevent-and-treat-them/)
- [Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?](https://scholariq.org/papers/sex-differences-in-tolerability-to-anti-programmed-cell-death-protein-1-therapy/)
- [Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites](https://scholariq.org/papers/aspergillus-fumigatus-inhibits-angiogenesis-through-the-production-of-gliotoxin/)
- [Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer](https://scholariq.org/papers/telehealth-vs-in-person-early-palliative-care-for-patients-with-advanced-lung/)
- [Using Genomics to Differentiate Multiple Primaries From Metastatic Lung Cancer](https://scholariq.org/papers/using-genomics-to-differentiate-multiple-primaries-from-metastatic-lung-cancer/)
- [The Faces of Financial Toxicity: A Qualitative Interview Study of Financial Toxicity in Advanced Cancer Patients in Phase I Oncology Trials](https://scholariq.org/papers/the-faces-of-financial-toxicity-a-qualitative-interview-study-of-financial/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer-related gene regulation](https://scholariq.org/topics/cancer-related-gene-regulation/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.